The oncogenic transformation driven by high-risk human papillomavirus (HPV), particularly HPV16 and HPV18, represents a multifactorial process that extends beyond the classical disruption of cancer suppressors such as p53 and pRb. The gene discussed is TP53; the disease is cancer.